DEV Community

FreyaLi
FreyaLi

Posted on

Boltz Raises 110 Million Dollars to Scale Molecular Design by the Token

#ai

Boltz Series A infographic

Boltz, an MIT spinout, closed a 110 million dollar Series A led by Bessemer with Andreessen Horowitz participating. It sells biomolecular foundation models by the token, and paid usage grew roughly 50-fold in four months.

Key facts

  • 110 million dollar Series A, after a 28 million dollar seed in January.
  • Six of the top 20 drugmakers are paying customers, including Pfizer, GSK, Takeda and Bristol Myers Squibb.
  • Open source models have more than 5 million downloads.
  • Boltz says a validated hit can cost as little as 10,000 dollars.

Full analysis: https://www.threerouter.com/blog/494

Sources: Endpoints News, Newscast Tech, Off Sand Hill, threerouter

Top comments (0)